{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:01:12Z","timestamp":1791925272368,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ajog.2014.10.1097","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T14:50:57Z","timestamp":1414680657000},"page":"485.e1-485.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial"],"prefix":"10.1016","volume":"212","author":[{"given":"Norbert","family":"Winer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Bretelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Victoire","family":"Senat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bohec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Deruelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Perrotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Connan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Vayssi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Capelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohreh","family":"Azimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Porcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8566-015X","authenticated-orcid":false,"given":"Patrick","family":"Rozenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2014.10.1097_bib1","first-page":"1","article-title":"Infant mortality statistics from the 2007 period linked birth\/infant death data set","volume":"59","author":"Mathews","year":"2011","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2014.10.1097_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jgyn.2012.04.014","article-title":"Trends in perinatal health in France from 1995 to 2010. Results from the French National Perinatal Surveys","volume":"41","author":"Blondel","year":"2012","journal-title":"J\u00a0Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.ajog.2014.10.1097_bib3","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","article-title":"Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000","volume":"379","author":"Liu","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2014.10.1097_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2014.10.1097_bib5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0002-9378(90)91084-P","article-title":"Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length","volume":"163","author":"Andersen","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199602293340904","article-title":"The length of the cervix and the risk of spontaneous premature delivery","volume":"334","author":"Iams","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2014.10.1097_bib7","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1067\/mob.2000.106851","article-title":"Patients with an ultrasonographic cervical length < or\u00a0= 15 mm have nearly a 50% risk of early spontaneous preterm delivery","volume":"182","author":"Hassan","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.AOG.0000270112.05025.1d","article-title":"Gestational age at cervical length measurement and incidence of preterm birth","volume":"110","author":"Berghella","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib9","article-title":"Precocious cervical ripening as a screening target to predict spontaneous preterm delivery among asymptomatic singleton pregnancies: a systematic review","author":"Li","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.AOG.0000150559.59531.b2","article-title":"Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials","volume":"105","author":"Sanchez-Ramos","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib11","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.ajog.2005.06.049","article-title":"Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials","volume":"194","author":"Mackenzie","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib12","doi-asserted-by":"crossref","first-page":"124.e1","DOI":"10.1016\/j.ajog.2011.12.003","article-title":"Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data","volume":"206","author":"Romero","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/AOG.0b013e3182699a15","article-title":"Progestogens for preterm birth prevention: a systematic review and meta-analysis","volume":"120","author":"Likis","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib14","first-page":"CD004947","article-title":"Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth","volume":"7","author":"Dodd","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2014.10.1097_bib15","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2014.10.1097_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"Da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O\u2019Brien","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib18","first-page":"963","article-title":"Use of progesterone to reduce preterm birth. ACOG Committee. Opinion no. 419 October 2008 (replaces no. 291, November 2003)","volume":"112","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajog.2012.03.010","article-title":"Progesterone and preterm birth prevention: translating clinical trials data into clinical practice","volume":"206","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2014.10.1097_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a\u00a0sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib22","doi-asserted-by":"crossref","first-page":"390.e1","DOI":"10.1016\/j.ajog.2012.09.013","article-title":"17 Alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm","volume":"207","author":"Grobman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1469-0705.2002.00645.x","article-title":"Transvaginal sonographic examination of the cervix in asymptomatic pregnant women: review of the literature","volume":"19","author":"Rozenberg","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib24","doi-asserted-by":"crossref","first-page":"206.e1","DOI":"10.1016\/j.ajog.2011.12.026","article-title":"Groupe de Recherche en Obst\u00e9trique et Gyn\u00e9cologie. Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial","volume":"206","author":"Rozenberg","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib25","doi-asserted-by":"crossref","first-page":"194.e1","DOI":"10.1016\/j.ajog.2013.01.032","article-title":"Groupe de Recherche en Obst\u00e9trique et Gyn\u00e9cologie. Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial","volume":"208","author":"Senat","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib26","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2307\/2533441","article-title":"Evaluation of experiments with adaptive interim analyses","volume":"50","author":"Bauer","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.ajog.2014.10.1097_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0197-2456(87)90027-4","article-title":"Conditional power calculations as an aid in the decision whether to continue a clinical trial","volume":"8","author":"Andersen","year":"1987","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ajog.2014.10.1097_bib28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa070641","article-title":"A\u00a0trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins","volume":"357","author":"Rouse","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2014.10.1097_bib29","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.ajog.2010.12.042","article-title":"17-Hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial","volume":"204","author":"Combs","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/AOG.0b013e31822ad6aa","article-title":"17\u03b1-Hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial","volume":"118","author":"Lim","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/AOG.0b013e318193c677","article-title":"Prevention of preterm birth in triplets using 17 alpha hydroxyprogesterone caproate: a randomized controlled trial","volume":"113","author":"Caritis","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib32","doi-asserted-by":"crossref","first-page":"248.e1","DOI":"10.1016\/j.ajog.2010.06.016","article-title":"Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial","volume":"203","author":"Combs","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib33","first-page":"804","article-title":"The effects of mifepristone on cervical ripening and labor induction in primigravidae","volume":"92","author":"Elliott","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib34","first-page":"793","article-title":"Induction of labor with mifepristone\u2014a randomized, double-blind study versus placebo","volume":"78","author":"Stenlund","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2014.10.1097_bib35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/humrep\/9.suppl_1.131","article-title":"The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery","volume":"9","author":"Chwalisz","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2014.10.1097_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1471-0528.1994.tb13150.x","article-title":"Mifepristone for labour induction after previous caesarean section","volume":"101","author":"Lelaidier","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib37","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/oxfordjournals.humrep.a136786","article-title":"Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses","volume":"3","author":"Frydman","year":"1988","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2014.10.1097_bib38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/uog.5174","article-title":"Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment","volume":"30","author":"Romero","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib39","doi-asserted-by":"crossref","first-page":"410.e1","DOI":"10.1016\/j.ajog.2009.07.009","article-title":"The effect of treatment with 17 alpha- hydroxyprogesterone caproate on changes in cervical length over time","volume":"201","author":"Durnwald","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib40","doi-asserted-by":"crossref","first-page":"269.e1","DOI":"10.1016\/j.ajog.2013.05.027","article-title":"The effect of intramuscular progesterone on the rate of cervical shortening","volume":"209","author":"Pessel","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib41","doi-asserted-by":"crossref","first-page":"455.e1","DOI":"10.1016\/j.ajog.2010.03.025","article-title":"Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle","volume":"202","author":"Kuon","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib42","doi-asserted-by":"crossref","first-page":"223.e1","DOI":"10.1016\/j.ajog.2013.01.020","article-title":"Prevention of preterm birth by progestational agents: what are the molecular mechanisms?","volume":"208","author":"Nold","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib43","doi-asserted-by":"crossref","first-page":"128.e1","DOI":"10.1016\/j.ajog.2013.10.008","article-title":"Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth","volume":"210","author":"Caritis","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajog.2005.12.002","article-title":"The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified? (Review)","volume":"194","author":"Romero","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib45","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0002-9378(99)70215-2","article-title":"The effect of therapeutic McDonald cerclage on cervical length as assessed by transvaginal ultrasonography","volume":"180","author":"Althuisius","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1067\/mob.2000.108874","article-title":"Cervical incompetence prevention randomized cerclage trial (CIPRACT): study design and preliminary results","volume":"183","author":"Althuisius","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib47","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1067\/mob.2001.118655","article-title":"Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone","volume":"185","author":"Althuisius","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib48","doi-asserted-by":"crossref","first-page":"260.e14","DOI":"10.1016\/j.ajog.2007.07.013","article-title":"Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?","volume":"197","author":"How","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/14767050601152845","article-title":"Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery","volume":"20","author":"Gonz\u00e1lez-Quintero","year":"2007","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2014.10.1097_bib50","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.286.11.1340","article-title":"Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth","volume":"286","author":"Owen","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2014.10.1097_bib51","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1136\/bmj.1.5130.1162","article-title":"Effect of castor oil, soap enema, and hot bath on the pregnant human uterus near term; a tocographic study","volume":"1","author":"Mathie","year":"1959","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2014.10.1097_bib52","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJM200309113491115","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"349","author":"Brancazio","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2014.10.1097_bib53","doi-asserted-by":"crossref","first-page":"453.e1","DOI":"10.1016\/j.ajog.2010.03.023","article-title":"17 alpha-Hydroxyprogesterone caproate vehicle, castor oil, enhances the contractile effect of oxytocin in human myometrium in pregnancy","volume":"202","author":"O\u2019Sullivan","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib54","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJMe078097","article-title":"Progesterone and preterm labor\u2013still no definite answers","volume":"357","author":"Thornton","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2014.10.1097_bib55","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.0730-7659.2004.00315.x","article-title":"Progesterone and preterm: seventy years of \u201cd\u00e9j\u00e0 vu\u201d or \u201cstill to be seen\u201d?","volume":"31","author":"Keirse","year":"2004","journal-title":"Birth"},{"key":"10.1016\/j.ajog.2014.10.1097_bib56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/jpm-2012-0272","article-title":"A\u00a0blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix","volume":"41","author":"Romero","year":"2013","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2014.10.1097_bib57","doi-asserted-by":"crossref","first-page":"131.e1","DOI":"10.1016\/j.ajog.2013.09.014","article-title":"The NICHD Consecutive Pregnancies Study: recurrent preterm delivery by subtype","volume":"210","author":"Laughon","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib58","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/uog.5159","article-title":"Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"DeFranco","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2014.10.1097_bib59","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ajog.2013.04.027","article-title":"Progesterone is not the same as 17\u03b1-hydroxyprogesterone caproate: implications for obstetrical practice","volume":"208","author":"Romero","year":"2013","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937814021528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937814021528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:33:06Z","timestamp":1762079586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937814021528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0002937814021528"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2014.10.1097","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2014.10.1097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}